News
GLP-1 RAs are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.
No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA vs DPP4i users.
For patients with idiopathic intracranial hypertension, GLP-1 RA treatment is linked to improved clinical outcomes compared with conventional therapies.
In this week’s Kern Cares, Dr. Hashimoto from BFMG joined host Kait Hill to unpack one of today’s most talked-about health ...
Stacker on MSN7h
How to find out if weight loss drugs are covered by your insurance, and what to do if they're not
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback